Methylphenidate differentially regulates c-fos and fosB expression in the developing rat striatum

Area of Science:

• Neuroscience
• Pharmacology
• Developmental Biology

Background:

• Methylphenidate (MPH) is a psychostimulant commonly prescribed for attention deficit hyperactivity disorder (ADHD) in children.
• Understanding MPH's central nervous system effects, particularly in developing brains, is crucial for assessing long-term implications.

Purpose of the Study:

• To investigate the differential effects of acute and repeated methylphenidate (MPH) administration on c-fos and fosB gene expression in the striatum of immature versus adult rats.
• To explore the enduring impact of early MPH exposure on gene expression patterns into adulthood.

Main Methods:

• Rats (prepubertal and adult) received daily saline or MPH (2 or 10 mg/kg) for 14 days, or a 13-day saline regimen followed by a single MPH dose.
• Long-term effects were assessed by challenging prepubertal rats with MPH in adulthood after a 4-week drug-free period.
• Expression of c-fos and fosB was quantified using immunohistochemistry for FOSB and cFOS proteins.

Main Results:

• Single-dose MPH increased FOSB expression in both immature and adult rat striata, with chronic MPH further elevating this in prepubertal rats.
• Repeated MPH inhibited cFOS expression in prepubertal rats and, at a higher dose, in adult rats.
• Reduced cFOS expression in prepubertal rats persisted into adulthood following MPH challenge, indicating enduring changes.

Conclusions:

• Repeated MPH treatment differentially regulates c-fos and fosB gene expression in immature and adult brains.
• MPH-induced alterations in gene expression demonstrate potential for long-lasting effects.
• The immature brain exhibits heightened sensitivity to the stimulant effects of MPH compared to the adult brain.